The Sleep Apnea Devices Market Size was valued at USD 4.69 billion in 2023 and is projected to reach USD 7.82 billion by 2031 with a growing CAGR of 6.60% Over the Forecast Period of 2023-2030.
The market for medical devices intended to diagnose, treat, and manage sleep apnea, a prevalent sleep disease characterised by breathing pauses while asleep, is referred to as the "sleep apnea devices market." These tools are designed to help people with sleep apnea have better quality sleep and overall health. A dangerous disorder called sleep apnea may cause a number of health concerns, such as cardiovascular troubles, excessive daytime drowsiness, and impaired cognitive function. It affects a substantial section of the world's population, and because of things like obesity, ageing populations, and lifestyle changes, its incidence is rising. Devices used to treat sleep apnea may be divided into three categories: accessories, treatment devices, and diagnostic equipment. Sleep studies or polysomnography are used as diagnostic tools to detect and gauge the severity of sleep apnea. These tools include portable monitoring tools, in-lab sleep studies, and at-home sleep apnea examinations. Continuous positive airway pressure (CPAP) therapy or other types of positive airway pressure (PAP) therapy are provided via therapeutic devices developed to cure sleep apnea. The most widely used CPAP devices consist of a mask worn over the nose or mouth that continuously delivers air to maintain the airway open while sleeping. Bilevel positive airway pressure (BiPAP) machines and adaptive servo-ventilation (ASV) devices are two further categories of therapeutic equipment.
Multiple lockdowns and implied travel restrictions were enforced by the continuing outbreak. Additionally, major infrastructure adjustments had to be made in healthcare institutions to stop the spread of the disease.The number of home sleep apnea testing services increased as a result of the decrease in diagnostic and treatment operations in sleep centres. The supply of services was disrupted, and elective treatments were delayed, due to the risk of viral transmission through aerosol-generating techniques like noninvasive ventilation. Multiple sleep study centres had to close as a result of this. The American Academy of Sleep Medicine (AASM) issued criteria and recommendations for the use of virtual care as the use of such care increased dramatically and consultations with patients increased as well. Studies show that healthcare professionals expect to keep more than 25% of virtual visits after the epidemic.
KEY DRIVERS:
Drivers:
A significant market driver is the growing prevalence of sleep apnea on a worldwide scale.
There is a rising demand for sleep apnea devices as people become more aware of the health dangers associated with untreated sleep apnea.
The increased incidence of sleep apnea is a result of factors including obesity, sedentary lifestyles, and ageing populations, which increases the need for diagnostic and treatment technologies. There is a rising demand for sleep apnea devices as people become more aware of the health dangers associated with untreated sleep apnea. Increased detection rates and subsequent treatment have resulted from improvements in diagnostic procedures that have made it simpler to recognise and diagnose sleep apnea. The comfort of patients, the effectiveness of the devices, and their ease of use have all been enhanced by ongoing technology developments in sleep apnea technologies. Wearable technologies, remote monitoring capabilities, and smaller, quieter devices have all helped to extend the market and increase patient compliance.
RESTRAIN:
CPAP machines and other therapeutic sleep apnea treatments can be very pricey.
The high price may make these devices less affordable and accessible for some patients, especially in developing countries, which would constrain market expansion. The long-term usage of devices is frequently necessary for the treatment of sleep apnea, and patient compliance can be quite difficult. The adoption and use of sleep apnea devices are impacted by non-compliance due to discomfort, mask fitting problems, and trouble adapting to therapy.
OPPORTUNITY:
Manufacturers may profit from this trend by creating portable, user-friendly products for sleep apnea management at home.
Manufacturers may tap into these markets by providing inexpensive, regionally specific solutions
Devices for treating sleep apnea at home are in high demand due to their affordability, ease, and patients' desire for in-home diagnosis and treatment with higher disposable incomes, better healthcare infrastructure and more awareness of sleep apnea, emerging markets have a huge market opportunity for sleep apnea devices.
CHALLENGES:
Adverse effects and side effects:
In certain areas, it may be difficult to diagnose and treat sleep apnea due to a lack of healthcare facilities and specialised sleep clinics
Patients who use sleep apnea devices may have dryness, nasal congestion, or skin irritation as a result of the devices. For the market to expand, these issues must be resolved and low-side-effect technologies must be created. There are issues that need to be resolved about expanding access to healthcare services and raising awareness in neglected communities.
The exact effect on the market for sleep apnea equipment will depend on the length and severity of the war as well as the geographic scope of its impacts, it is vital to highlight. The Russian-Ukrainian conflict is simply one of several worldwide variables that have an impact on the market's behaviour.
The war may affect the supply of sleep apnea equipment if it affects the region's political stability or disrupts transportation routes. It may be difficult for manufacturers or suppliers based in or dependent on the impacted areas to find raw materials or get completed goods to market. The supply of sleep apnea devices might be impacted by production and delivery delays brought on by this interruption. The conflict may lead to regional economic unpredictability, which might affect consumer purchasing power. The demand for sleep apnea devices may decline as a result of economic unpredictability and currency volatility because people may choose to prioritise fundamental requirements over luxuries like healthcare equipment.
IMPACT OF ONGOING RECESSION:
During a recession, people and households frequently have financial difficulties and may choose to spend their money on necessities instead of luxury items like healthcare. Devices for treating sleep apnea, particularly CPAP machines, may be rather pricey. Due to this, consumer expenditure on sleep apnea equipment may fall, which would temporarily reduce market demand. During a recession, affordability takes on greater importance, and people may be more hesitant to buy sleep apnea equipment altogether owing to financial worries. Economic downturns may also have an impact on insurance coverage and reimbursement practises, which can restrict access to sleep apnea devices for people who depend on insurance to cover their medical costs. People with sleep apnea symptoms may put off getting treatment during a recession because of concerns about their finances or a lack of insurance. The market for sleep apnea devices may be impacted as a result of the short-term decline in demand for diagnostic and therapeutic devices due to the delay in diagnosis and treatment.
By Product type
Medical gadgets
Diagnostic equipment
By End users
Sleep research facilities
Setting/Individual Home Care
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin American
Key players are ResMed, Phillips Respironics, Fisher & Paykel Healthcare Limited, Curative Medical, Inc., Invacare Corporation, Somnetics International, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, SOMNOmedics GmbH, Compumedics Limited, Itamar Medical Ltd, and other players listed in the final report.
ResMed: WASHINGTON, May 25, 2023. At the American Thoracic Society International Conference, renowned medical professionals presented fresh data demonstrating treating obstructive sleep apnea (OSA) with positive airway pressure (PAP) treatment decreases patients' all-cause mortality. Additionally, a recently published abstract demonstrated that treating central sleep apnea (CSA) led to a "significant and clinically relevant improvement" in patients' symptoms and quality of life.
| Report Attributes | Details |
| Market Size in 2023 | US$ 4.69 Bn |
| Market Size by 2031 | US$ 7.82 Bn |
| CAGR | CAGR of 6.60 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Medical gadgets, Diagnostic equipment) • By End users (Sleep research facilities, Setting/Individual Home Care) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | ResMed, Phillips Respironics, Fisher & Paykel Healthcare Limited, Curative Medical, Inc., Invacare Corporation, Somnetics International, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, SOMNOmedics GmbH, Compumedics Limited, Itamar Medical Ltd |
| Key Drivers | • A significant market driver is the growing prevalence of sleep apnea on a worldwide scale. • There is a rising demand for sleep apnea devices as people become more aware of the health dangers associated with untreated sleep apnea. |
| Market Opportunities | • Manufacturers may profit from this trend by creating portable, user-friendly products for sleep apnea management at home. • Manufacturers may tap into these markets by providing inexpensive, regionally specific solutions |
Ans: The size of Sleep Apnea Devices market is approx. USD 4.4 billion in 2022.
Ans: The CAGR Growth rate of Sleep Apnea Devices Market is approx. at a CAGR of 6.4% from 2023 to 2030.
Ans: Some key players operating in the sleep apnea devices market include Curative Medical Inc.; Philips Respironics; ResMed; Fisher & Paykel Healthcare; Cadwell Laboratories; and Invacare Corporation.
Ans: The rising prevalence of obstructive sleep apnea (OSA) patients is one of the major reasons fuelling the growth of the sleep apnea devices market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global Sleep Apnea Devices market, By Product
8.1 Whole Slide Imaging Systems
8.2 Image Analysis Software
8.3 Storage and Communication Systems
9. Global Sleep Apnea Devices market, By End-User
9.1 Veterinary Hospitals and Clinics
9.2 Veterinary Reference Laboratories
9.3 Veterinary Research Institutes
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Sleep Apnea Devices Market by country
10.2.2North America Sleep Apnea Devices Market by Product Type
10.2.3 North America Sleep Apnea Devices Market by End-User
10.2.4 USA
10.2.4.1 USA Sleep Apnea Devices Market by Product Type
10.2.4.2 USA Sleep Apnea Devices Market by End-User
10.2.7 Canada
10.2.7.1 Canada Sleep Apnea Devices Market by Product Type
10.2.7.2 Canada Sleep Apnea Devices Market by End-User
10.2.8 Mexico
10.2.8.1 Mexico Sleep Apnea Devices Market by Product Type
10.2.8.2 Mexico Sleep Apnea Devices Market by End-User
10.3 Europe
10.3.1 Europe Sleep Apnea Devices Market by country
10.3.2 Europe Sleep Apnea Devices Market by Product Type
10.3.3 Europe Sleep Apnea Devices Market by End-User
10.3.6 Germany
10.3.6.1 Germany Sleep Apnea Devices Market by Product Type
10.3.6.2 Germany Sleep Apnea Devices Market by End-User
10.3.7 UK
10.3.7.1 UK Sleep Apnea Devices Market by Product Type
10.3.7.2 UK Sleep Apnea Devices Market by End-User
10.3.8 France
10.3.8.1 France Sleep Apnea Devices Market by Product Type
10.3.8.2 France Sleep Apnea Devices Market by End-User
10.3.9 Italy
10.3.9.1 Italy Sleep Apnea Devices Market by Product Type
10.3.9.2 Italy Sleep Apnea Devices Market by End-User
10.3.10 Spain
10.3.10.1 Spain Sleep Apnea Devices Market by Product Type
10.3.10.2 Spain Sleep Apnea Devices Market by End-User
10.3.11 The Netherlands
10.3.11.1 Netherlands Sleep Apnea Devices Market by Product Type
10.3.11.2 Netherlands Sleep Apnea Devices Market by End-User
10.3.12 Rest of Europe
10.3.12.1 Rest of Europe Sleep Apnea Devices Market by Product Type
10.3.12.2 Rest of Europe Sleep Apnea Devices Market by End-User
10.4 Asia-Pacific
10.4.1 Asia Pacific Sleep Apnea Devices Market by country
10.4.2 Asia Pacific Sleep Apnea Devices Market by Product Type
10.4.3 Asia Pacific Sleep Apnea Devices Market by End-User
10.4.6 Japan
10.4.6.1 Japan Sleep Apnea Devices Market by Product Type
10.4.6.2 Japan Sleep Apnea Devices Market by End-User
10.4.7 South Korea
10.4.7.1 South Korea Sleep Apnea Devices Market by Product Type
10.4.7.2 South Korea Sleep Apnea Devices Market by End-User
10.4.8 China
10.4.8.1 China Sleep Apnea Devices Market by Product Type
10.4.8.2 China Sleep Apnea Devices Market by End-User
10.4.9 India
10.4.9.1 India Sleep Apnea Devices Market by Product Type
10.4.9.2 India Sleep Apnea Devices Market by End-User
10.4.10 Australia
10.4.10.1 Australia Sleep Apnea Devices Market by Product Type
10.4.10.2 Australia Sleep Apnea Devices Market by End-User
10.4.11 Rest of Asia-Pacific
10.4.11.1 APAC Sleep Apnea Devices Market by Product Type
10.4.11.2 APAC Sleep Apnea Devices Market by End-User
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Sleep Apnea Devices Market by country
10.5.2 The Middle East & Africa Sleep Apnea Devices Market by Product Type
10.5.3 The Middle East & Africa Sleep Apnea Devices Market by End-User
10.5.6 Israel
10.5.6.1 Israel Sleep Apnea Devices Market by Product Type
10.5.6.2 Israel Sleep Apnea Devices Market by End-User
10.5.7 UAE
10.5.7.1 UAE Sleep Apnea Devices Market by Product Type
10.5.7.2 UAE Sleep Apnea Devices Market by End-User
10.5.8 South Africa
10.5.8.1 South Africa Sleep Apnea Devices Market by Product Type
10.5.8.2 South Africa Sleep Apnea Devices Market by End-User
10.5.9 Rest of Middle East & Africa
10.5.9.1 Rest of Middle East & Asia Sleep Apnea Devices Market by Product Type
10.5.9.2 Rest of Middle East & Asia Sleep Apnea Devices Market by End-User
10.6 Latin America
10.6.1 Latin America Sleep Apnea Devices Market by country
10.6.2 Latin America Sleep Apnea Devices Market by Product Type
10.6.3 Latin America Sleep Apnea Devices Market by End-User
10.6.6 Brazil
10.6.6.1 Brazil Sleep Apnea Devices Market by Product Type
10.6.6.2 Brazil Africa Sleep Apnea Devices Market by End-User
10.6.7 Argentina
10.6.7.1 Argentina Sleep Apnea Devices Market by Product Type
10.6.7.2 Argentina Sleep Apnea Devices Market by End-User
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Sleep Apnea Devices Market by Product Type
10.6.8.2 Rest of Latin America Sleep Apnea Devices Market by End-User
12 Company profile
12.1 ResMed
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Treatment/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Phillips Respironics
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Treatment/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Fisher & Paykel Healthcare Limited
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Treatment/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Curative Medical, Inc.
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Treatment/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Invacare Corporation
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Treatment/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Somnetics International, Inc.
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Treatment/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 BMC Medical Co., Ltd
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Treatment/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Natus Medical Incorporated
12.8.1 Market Overview
12.8.2 Financials
12.8.3 Treatment/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 SOMNOmedics GmbH,
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Treatment/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Compumedics Limited
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Treatment/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Drug Delivery Systems Market was valued at USD 42.80 Billion in 2023 and is expected to reach USD 87.82 Billion By 2031 and grow at a CAGR of 9.4% over the forecast period of 2024-2031.
The Nebulizer Market was estimated at USD 1.14 billion in 2023 and is poised to reach at 1.83 billion in 2031 anticipated to expand at a compound annual growth rate approx. CAGR of 6.07% for the forecast period of 2024-2031.
The Computer Vision in Healthcare Market Size was valued at USD 1.46 billion in 2023, and is expected to reach USD 33.32 billion by 2031, and grow at a CAGR of 47.8% over the forecast period 2024-2031.
The 3D Ultrasound Market was estimated at USD 3.65 billion in 2022 and is poised to reach USD 6.17 billion in 2030 anticipated to expand at a compound annual growth rate of approx. CAGR of 6.8% for the forecast period of 2023-2030.
The Circulating Tumor Cells Market size was estimated USD 10.4 billion in 2022 and is expected to reach USD 28.4 billion by 2030 at a CAGR of 13.4% during the forecast period of 2023-2030.
The Medical Waste Containers Market Size was valued at USD 1.89 billion in 2022 and is expected to reach USD 3.02 billion by 2030, and grow at a CAGR of 6.0% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
